BackSilexion Therapeutics - Warrants(14/08/2029) Overview

Silexion Therapeutics - Warrants(14/08/2029) Long Term Debt

Track Silexion Therapeutics - Warrants(14/08/2029)'s long-term debt ($230K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$226000.00
↓ 93.59% YoYΔ $-3.30M vs prior year quarter

Peer trimmed avg / median

Loading

Silexion Therapeutics - Warrants(14/08/2029) Long Term Debt History

Loading

Silexion Therapeutics - Warrants(14/08/2029) vs. peers: Long Term Debt Comparison

Loading

Silexion Therapeutics - Warrants(14/08/2029) Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Silexion Therapeutics - Warrants(14/08/2029) (SLXNW) FAQ

As of the most recent data (June 2026), SLXNW shows a long-term debt of $230K. That compares with $3.5M in the prior-year period — down 93.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLXNW's long-term debt is now $230K (was $3.5M) — a 93.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Silexion Therapeutics - Warrants(14/08/2029) is outperforming or lagging.

Tracking SLXNW's long-term debt over time shows whether Silexion Therapeutics - Warrants(14/08/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $230K That compares with $3.5M in the prior-year period — down 93.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Silexion Therapeutics - Warrants(14/08/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $230K) with ownership activity and broader fundamentals.